These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27091156)

  • 1. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.
    Lefere S; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Devisscher L; Geerts A
    Cell Mol Life Sci; 2016 Sep; 73(18):3419-31. PubMed ID: 27091156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and fatty liver.
    Suzuki T; Shinjo S; Arai T; Kanai M; Goda N
    World J Gastroenterol; 2014 Nov; 20(41):15087-97. PubMed ID: 25386057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGFRβ + cell HIF2α is dispensable for white adipose tissue metabolic remodeling and hepatic lipid accumulation in obese mice.
    Yao T; Wei D; Tian X; Zhao L; Wan Q; Zhang X; Cai J; Li S; Diao B; Feng S; Shan B; Shao M; Wu Y
    Lipids Health Dis; 2024 Mar; 23(1):81. PubMed ID: 38509584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases.
    Eltzschig HK; Bratton DL; Colgan SP
    Nat Rev Drug Discov; 2014 Nov; 13(11):852-69. PubMed ID: 25359381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
    Strowitzki MJ; Ritter AS; Kimmer G; Schneider M
    Pharmacol Res; 2019 Sep; 147():104364. PubMed ID: 31376431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration.
    Fan L; Li J; Yu Z; Dang X; Wang K
    Biomed Res Int; 2014; 2014():239356. PubMed ID: 24895555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of HIF-2α PAS-B domain contributes to physiological responses.
    Feng Z; Zou X; Chen Y; Wang H; Duan Y; Bruick RK
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13240-13245. PubMed ID: 30523118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M.
    Poblete JMS; Ballinger MN; Bao S; Alghothani M; Nevado JB; Eubank TD; Christman JW; Magalang UJ
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E689-E700. PubMed ID: 32154744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
    Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
    J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-liver cross-talk: a route to hepatic dysfunction in pregnant women with obesity.
    Sousa D; Magalhães CC; Matafome P; Pereira SP
    Biosci Rep; 2024 Aug; 44(8):. PubMed ID: 39083072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2α.
    Cao R; Zhao X; Li S; Zhou H; Chen W; Ren L; Zhou X; Zhang H; Shi R
    Cell Physiol Biochem; 2014; 34(5):1427-41. PubMed ID: 25323790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged fasting activates hypoxia inducible factors-1α, -2α and -3α in a tissue-specific manner in northern elephant seal pups.
    Soñanez-Organis JG; Vázquez-Medina JP; Crocker DE; Ortiz RM
    Gene; 2013 Sep; 526(2):155-63. PubMed ID: 23707926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
    Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
    Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress on the role of HIFs-PHDs oxygen-sensing pathway in cellular ferroptosis].
    Zhou J; Li F; Zhu XY; Shen HJ; Lu RZ
    Sheng Li Xue Bao; 2021 Dec; 73(6):1017-1024. PubMed ID: 34961876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
    Cai H; Bai Z; Ge RL
    Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
    Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
    Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.